What can we learn about stroke from retinal ischemia models?

Acta Pharmacologica Sinica

Volumn 34, Issue 1, 2013, Pages 91-103

  D'Onofrio, Philippe M ^a   Koeberle, Paulo D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

apoptosis; cell death pathway; central nervous system; excitotoxicity; ischemia; necrosis; neurotrophic factor; retina

Indexed keywords

NEUROTROPHIC FACTOR;

ANIMAL MODEL; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; EXCITOTOXICITY; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; RETINA BLOOD FLOW; RETINA ISCHEMIA; REVIEW;

ANIMALS; CELL DEATH; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIA; NERVE GROWTH FACTORS; RETINA; RETINAL DISEASES; RETINAL VESSELS; STROKE;

EID: 84872062190     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.165     Document Type: Review

References (217)

1. van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med 2007;357:572-9. (Pubitemid 47236282)
2. Muthaian R, Minhas G, Anand A. Pathophysiology of stroke and stroke-induced retinal ischemia: emerging role of stem cells. J Cell Physiol 2012;227:1269-79.
3. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89:1132-45. (Pubitemid 12003230)
4. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23:91-147. (Pubitemid 38180539)
5. Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke 2008;39:1371-9. (Pubitemid 351440721)
6. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007;87:179-97. (Pubitemid 46860315)
7. McCabe C, Gallagher L, Gsell W, Graham D, Dominiczak AF, Macrae IM. Differences in the evolution of the ischemic penumbra in strokeprone spontaneously hypertensive and Wistar-Kyoto rats. Stroke 2009;40:3864-8.
8. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7. (Pubitemid 29453643)
9. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4:399-415. (Pubitemid 37280178)
10. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 2004;19:151-67. (Pubitemid 39361178)
11. Minhas G, Morishita R, Anand A. Preclinical models to investigate retinal ischemia: advances and drawbacks. Front Neurol 2012;3:75.
12. Sugiyama K, Gu ZB, Kawase C, Yamamoto T, Kitazawa Y. Optic nerve and peripapillary choroidal microvasculature of the rat eye. Invest Ophthalmol Vis Sci 1999;40:3084-90.
13. Foulds WS, Johnson NF. Rabbit electroretinogram during recovery from induced ischaemia. Trans Ophthalmol Soc U K 1974;94:383-93.
14. Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci 1996;37:2002-14. (Pubitemid 26321693)
15. Smith GG, Baird CD. Survival time of retinal cells when deprived of their blood supply by increased intraocular pressure. Am J Ophthalmol 1952;35:133-6.
16. Buchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 1991;203:138-47.
17. Magharious MM, D'Onofrio PM, Koeberle PD. Methods for experimental manipulations after optic nerve transection in the Mammalian CNS. J Vis Exp 2011;51:e2261.
18. Magharious MM, D'Onofrio PM, Koeberle PD. Optic nerve transection: a model of adult neuron apoptosis in the central nervous system. J Vis Exp 2011;51:e2241.
19. Gehlbach P, Purple RL. Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion. Invest Ophthalmol Vis Sci 1994;35:669-76. (Pubitemid 24078126)
20. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985;17:497-504. (Pubitemid 15019990)
21. Schmidt A, Hoppen M, Strecker JK, Diederich K, Schabitz WR, Schilling M, et al. Photochemically induced ischemic stroke in rats. Exp Transl Stroke Med 2012;4:13.
22. Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 1991;113:10-7.
23. Romano C, Price M, Bai HY, Olney JW. Neuroprotectants in Honghua: glucose attenuates retinal ischemic damage. Invest Ophthalmol Vis Sci 1993;34:72-80. (Pubitemid 23045104)
24. Daugeliene L, Niwa M, Hara A, Matsuno H, Yamamoto T, Kitazawa Y, et al. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion. Invest Ophthalmol Vis Sci 2000;41:2743-7. (Pubitemid 30624408)
25. Macrae IM. Preclinical stroke research - advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol 2011;164:1062-78.
26. Buchi ER, Lam TT, Suvaizdis I, Tso MO. Injuries induced by diffuse photodynamic action in retina and choroid of albino rats. Mor phologic study of an experimental model. Retina 1994;14:370-8. (Pubitemid 24310159)
27. Hollander A, D'Onofrio PM, Magharious MM, Lysko MD, Koeberle PD. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells. Invest Ophthalmol Vis Sci 2012;53:3973-89.
28. Magharious M, D'Onofrio PM, Hollander A, Zhu P, Chen J, Koeberle PD. Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush. J Proteome Res 2011;10:3344-62.
29. Coblentz FE, Radeke MJ, Lewis GP, Fisher SK. Evidence that ganglion cells react to retinal detachment. Exp Eye Res 2003;76:333-42. (Pubitemid 36263332)
30. Ju WK, Gwon JS, Park SJ, Kim KY, Moon JI, Lee MY, et al. Growth-associated protein 43 is up-regulated in the ganglion cells of the ischemic rat retina. Neuroreport 2002;13:861-5.
31. Oestreicher AB, De Graan PN, Gispen WH, Verhaagen J, Schrama LH. B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog Neurobiol 1997;53:627-86. (Pubitemid 28023417)
32. Frey D, Laux T, Xu L, Schneider C, Caroni P. Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol 2000;149:1443-54.
33. Ekstrom P, Johansson K. Differentiation of ganglion cells and amacrine cells in the rat retina: correlation with expression of HuC/D and GAP-43 proteins. Brain Res Dev Brain Res 2003;145:1-8. (Pubitemid 38368636)
34. Isenmann S, Kretz A, Cellerino A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog Retin Eye Res 2003;22:483-543. (Pubitemid 36559607)
35. Chu D, Qiu J, Grafe M, Fabian R, Kent TA, Rassin D, et al. Delayed cell death signaling in traumatized central nervous system: hypoxia. Neurochem Res 2002;27:97-106. (Pubitemid 34245404)
36. Graham SH, Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001;21:99-109. (Pubitemid 32143971)
37. Kaushik S, Pandav SS, Ram J. Neuroprotection in glaucoma. J Postgrad Med 2003;49:90-5. (Pubitemid 36758280)
38. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012;19:75-86.
39. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005;1:112-9.
40. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemiareperfusion injury model. J Neurosci Res 2010;88:1569-76.
41. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008;135:1311-23.
42. Yuan J, Kroemer G. Alternative cell death mechanisms in development and beyond. Genes Dev 2010;24:2592-602.
43. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a wellorchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006;1757:1371-87. (Pubitemid 44472550)
44. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-14.
45. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000;1:489-95.
46. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008;4:313-21. (Pubitemid 351550892)
47. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009;137:1112-23.
48. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009;137:1100-11.
49. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009;325:332-6.
50. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of the caspase-8-FLIP (L) complex inhibits RIPK3-dependent necrosis. Nature 2011;471:363-7.
51. Upton JW, Kaiser WJ, Mocarski ES. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010;7:302-13.
52. Teng X, Degterev A, Jagtap P, Xing X, Choi S, Denu R, et al. Structureactivity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 2005;15:5039-44. (Pubitemid 41400181)
53. Norbury CJ, Hickson ID. Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001;41:367-401. (Pubitemid 32385892)
54. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999;19:3809-17. (Pubitemid 29222257)
55. Lam TT, Abler AS, Tso MO. Apoptosis and caspases after ischemiareperfusion injury in rat retina. Invest Ophthalmol Vis Sci 1999;40:967-75. (Pubitemid 29153263)
56. Hacker G. The morphology of apoptosis. Cell Tissue Res 2000;301:5-17. (Pubitemid 30459851)
57. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
58. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516. (Pubitemid 46911891)
59. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000;407:784-8.
60. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J Immunol 2003;171:4672-9. (Pubitemid 37310584)
61. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002;2:277-88. (Pubitemid 37328781)
62. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspaseindependent mitochondrial damage, a required first step for apoptosis. Immunity 2005;22:355-70. (Pubitemid 40387477)
63. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
64. Baumgartner R, Meder G, Briand C, Decock A, D'Arcy A, Hassiepen U, et al. The crystal structure of caspase-6, a selective effector of axonal degeneration. Biochem J 2009;423:429-39.
65. Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 2009;16:1053-61.
66. Yi CH, Yuan J. The Jekyll and Hyde functions of caspases. Dev Cell 2009;16:21-34.
67. Kermer P, Klocker N, Labes M, Bahr M. Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 1998;18:4656-62. (Pubitemid 28280174)
68. Kermer P, Klocker N, Bahr M. Long-term effect of inhibition of ced 3-like caspases on the survival of axotomized retinal ganglion cells in vivo. Exp Neurol 1999;158:202-5. (Pubitemid 29344332)
69. Kermer P, Ankerhold R, Klocker N, Krajewski S, Reed JC, Bahr M. Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 2000;85:144-50. (Pubitemid 32056245)
70. Chaudhary P, Ahmed F, Quebada P, Sharma SC. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res Mol Brain Res 1999;67:36-45. (Pubitemid 29170066)
71. Weishaupt JH, Diem R, Kermer P, Krajewski S, Reed JC, Bahr M. Contribution of caspase-8 to apoptosis of axotomized rat retinal ganglion cells in vivo. Neurobiol Dis 2003;13:124-35. (Pubitemid 36793977)
72. Cheung ZH, Chan YM, Siu FK, Yip HK, Wu W, Leung MC, et al. Regulation of caspase activation in axotomized retinal ganglion cells. Mol Cell Neurosci 2004;25:38-93.
73. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368-72. (Pubitemid 26408520)
74. Finn JT, Weil M, Archer F, Siman R, Srinivasan A, Raff MC. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000;20:1333-41. (Pubitemid 30220412)
75. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009;457:981-9.
76. Monnier PP, D'Onofrio PM, Magharious M, Hollander AC, Tassew N, Szydlowska K, et al. Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci 2011;31:10494-505.
77. Ahmed Z, Kalinski H, Berry M, Almasieh M, Ashush H, Slager N, et al. Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis 2011;2:e173.
78. Rai NK, Tripathi K, Sharma D, Shukla VK. Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 2005;4:138-44. (Pubitemid 41437580)
79. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16. (Pubitemid 27386911)
80. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501. (Pubitemid 32201945)
81. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8. (Pubitemid 28406815)
82. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997;272:32401-10. (Pubitemid 28011923)
83. Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 1998;8:525-8. (Pubitemid 28203072)
84. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998;10:545-51. (Pubitemid 28479187)
85. Suliman A, Lam A, Datta R, Srivastava RK. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 2001;20:2122-33. (Pubitemid 32424006)
86. Rubio-Moscardo F, Blesa D, Mestre C, Siebert R, Balasas T, Benito A, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 2005;106:3214-22. (Pubitemid 41565921)
87. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002;296:1635-6. (Pubitemid 34579146)
88. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al. Cytotoxicity-dependent APO-1 (Fas/CD95) - associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995;14:5579-88.
89. Kataoka T, Schroter M, Hahne M, Schneider P, Irmler M, Thome M, et al. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol 1998;161:3936-42. (Pubitemid 28468969)
90. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999;274:1541-8.
91. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-90. (Pubitemid 36936912)
92. Declercq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009;138:229-32.
93. Sun X, Yin J, Starovasnik MA, Fairbrother WJ, Dixit VM. Identification of a novel homotypic interaction motif required for the phos phoryl ation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 2002;277:9505-11. (Pubitemid 34953039)
94. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004;23:2861-74. (Pubitemid 38638848)
95. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006;13:1423-33. (Pubitemid 44210346)
96. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-ordeath switch. Nat Rev Cancer 2002;2:647-56. (Pubitemid 37328916)
97. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-736. (Pubitemid 32695243)
98. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317. (Pubitemid 26080831)
99. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217-81. (Pubitemid 32695259)
100. Westermann R, Grothe C, Unsicker K. Basic fibroblast growth factor (bFGF), a multifunctional growth factor for neuroectodermal cells. J Cell Sci Suppl 1990;13:97-117.
101. Baehr M, Bunge RP. Functional status influences the ability of Schwann cells to support adult rat retinal ganglion cell survival and axonal regrowth. Exp Neurol 1989;106:27-40. (Pubitemid 19246447)
102. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, La Vail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83-6.
103. Zhang C, Takahashi K, Lam TT, Tso MO. Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci 1994;35:3163-8. (Pubitemid 24241354)
104. Unoki K, La Vail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994;35:907-15. (Pubitemid 24079821)
105. Wu WC, Lai CC, Chen SL, Sun MH, Xiao X, Chen TL, et al. GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol Vis 2004;10:93-102. (Pubitemid 38628971)
106. Brantley MA Jr, Jain S, Barr EE, Johnson EM Jr, Milbrandt J. Neurturin-mediated ret activation is required for retinal function. J Neurosci 2008;28:4123-35.
107. Baloh RH, Enomoto H, Johnson EM Jr, Milbrandt J. The GDNF family ligands and receptors-implications for neural development. Curr Opin Neurobiol 2000;10:103-10. (Pubitemid 30102862)
108. Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 2003;116:3855-62. (Pubitemid 37279301)
109. Harada C, Harada T, Quah HM, Maekawa F, Yoshida K, Ohno S, et al. Potential role of glial cell line-derived neurotrophic factor receptors in Muller glial cells during light-induced retinal degeneration. Neuroscience 2003;122:229-35. (Pubitemid 37329961)
110. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003;29:211-30. (Pubitemid 36718170)
111. Jelsma TN, Friedman HH, Berkelaar M, Bray GM, Aguayo AJ. Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve. J Neurobiol 1993;24:1207-14. (Pubitemid 23239160)
112. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A 1994;91:1632-6. (Pubitemid 24080259)
113. Perez MT, Caminos E. Expression of brain-derived neurotrophic factor and of its functional receptor in neonatal and adult rat retina. Neurosci Lett 1995;183:96-9.
114. Thanos S, Vanselow J. The effect of central and peripheral neuroglia on the regeneration of the optic nerve. Fortschr Ophthalmol 1989;86:172-5. (Pubitemid 19135252)
115. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 1989;9:1263-72. (Pubitemid 19116746)
116. Cohen-Cory S, Fraser SE. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 1995;378:192-6.
117. Ko ML, Hu DN, Ritch R, Sharma SC, Chen CF. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administra tion in hypertensive eyes of rats. Neurosci Lett 2001;305:139-42. (Pubitemid 33762785)
118. Clarke DB, Bray GM, Aguayo AJ. Prolonged administration of NT-4/5 fails to rescue most axotomized retinal ganglion cells in adult rats. Vision Res 1998;38:1517-24. (Pubitemid 28239270)
119. Park HY, Kim JH, Sun Kim H, Park CK. Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina. Brain Res 2012;1469:10-23.
120. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002;22:3977-86. (Pubitemid 37465706)
121. Ghinelli E, Johansson J, Rios JD, Chen LL, Zoukhri D, Hodges RR, et al. Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland. Invest Ophthalmol Vis Sci 2003;44:3352-7. (Pubitemid 36909770)
122. Muzi S, Colafrancesco V, Sornelli F, Mantelli F, Lambiase A, Aloe L. Nerve growth factor in the developing and adult lacrimal glands of rat with and without inherited retinitis pigmentosa. Cornea 2010;29:1163-8.
123. Lambiase A, Micera A, Sgrulletta R, Bonini S. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr Opin Allergy Clin Immunol 2004;4:425-30. (Pubitemid 39274085)
124. Lambiase A, Micera A, Pellegrini G, Merlo D, Rama P, De Luca M, et al. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci 2009;50:4622-30.
125. Micera A, Lambiase A, Puxeddu I, Aloe L, Stampachiacchiere B, Levi-Schaffer F, et al. Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing. Exp Eye Res 2006;83:747-57. (Pubitemid 44308611)
126. Lambiase A, Mantelli F, Sacchetti M, Rossi S, Aloe L, Bonini S. Clinical applications of NGF in ocular diseases. Arch Ital Biol 2011;149:283-92.
127. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 1993;34:3232-45. (Pubitemid 23346655)
128. Colafrancesco V, Coassin M, Rossi S, Aloe L. Effect of eye NGF admini stration on two animal models of retinal ganglion cells degeneration. Ann Ist Super Sanita 2011;47:284-9.
129. Kokona D, Charalampopoulos I, Pediaditakis I, Gravanis A, Thermos K. The neurosteroid dehydroepiandrosterone (DHEA) protects the retina from AMPA-induced excitotoxicity: NGF TrkA receptor involvement. Neuro pharmacology 2012;62:2106-17.
130. Frade JM, Bovolenta P, Rodriguez-Tebar A. Neurotrophins and other growth factors in the generation of retinal neurons. Microsc Res Tech 1999;45:243-51. (Pubitemid 29264988)
131. Ichim G, Tauszig-Delamasure S, Mehlen P. Neurotrophins and cell death. Exp Cell Res 2012;318:1221-8.
132. Tauszig-Delamasure S, Yu LY, Cabrera JR, Bouzas-Rodriguez J, Mermet-Bouvier C, Guix C, et al.. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci U S A 2007;104:13361-6. (Pubitemid 47293950)
133. Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010;467:59-63.
134. von Bartheld CS, Wang X, Butowt R. Anterograde axonal transport, trans cytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol Neurobiol 2001;24:1-28. (Pubitemid 34066675)
135. Su KG, Banker G, Bourdette D, Forte M. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep 2009;9:411-7.
136. Caleo M, Medini P, von Bartheld CS, Maffei L. Provision of brainderived neurotrophic factor via anterograde transport from the eye preserves the physiological responses of axotomized geniculate neurons. J Neurosci 2003;23:287-96. (Pubitemid 36050429)
137. Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA, et al. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci 1998;18:2808-21. (Pubitemid 28163211)
138. Zhang J, Shi Q, Yang P, Xu X, Chen X, Qi C, et al. Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats. Neuroscience 2012;222:1-9.
139. Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997;17:9583-95. (Pubitemid 28006402)
140. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991;7:857-66.
141. Glebova NO, Ginty DD. Heterogeneous requirement of NGF for sympathetic target innervation in vivo. J Neurosci 2004;24:743-51. (Pubitemid 38166500)
142. English AW, Meador W, Carrasco DI. Neurotrophin-4/5 is required for the early growth of regenerating axons in peripheral nerves. Eur J Neurosci 2005;21:2624-34. (Pubitemid 40835106)
143. English AW, Schwartz G, Meador W, Sabatier MJ, Mulligan A. Electrical stimulation promotes peripheral axon regeneration by enhanced neuronal neurotrophin signaling. Dev Neurobiol 2007;67:158-72.
144. Chan KM, Lam DT, Pong K, Widmer HR, Hefti F. Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion. Neurochem Res 1996;21:763-7. (Pubitemid 26284771)
145. Zhi Y, Lu Q, Zhang CW, Yip HK, So KF, Cui Q. Different optic nerve injury sites result in different responses of retinal ganglion cells to brain-derived neurotrophic factor but not neurotrophin-4/5. Brain Res 2005;1047:224-32. (Pubitemid 40799317)
146. Holtmann B, Wiese S, Samsam M, Grohmann K, Pennica D, Martini R, et al. Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. J Neurosci 2005;25:1778-87. (Pubitemid 40279283)
147. Ip NY. The neurotrophins and neuropoietic cytokines: two families of growth factors acting on neural and hematopoietic cells. Ann N Y Acad Sci 1998;840:97-106.
148. Stockli KA, Lottspeich F, Sendtner M, Masiakowski P, Carroll P, Gotz R, et al. Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 1989;342:920-3. (Pubitemid 20021337)
149. Park CK, Ju WK, Hofmann HD, Kirsch M, Ki Kang J, Chun MH, et al. Differential regulation of ciliary neurotrophic factor and its receptor in the rat hippocampus following transient global ischemia. Brain Res 2000;861:345-53. (Pubitemid 30173320)
150. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002;8:620-4. (Pubitemid 34633441)
151. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology 1996;46:1244-9.
152. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann Neurol 1996;39:256-60. (Pubitemid 26071576)
153. Weise J, Isenmann S, Klocker N, Kugler S, Hirsch S, Gravel C, et al. Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo. Neurobiol Dis 2000;7:212-23. (Pubitemid 30451035)
154. Isenmann S, Klocker N, Gravel C, Bahr M. Short communication: protection of axotomized retinal ganglion cells by adenovirally delivered BDNF in vivo. Eur J Neurosci 1998;10:2751-6. (Pubitemid 28362584)
155. Klocker N, Braunling F, Isenmann S, Bahr M. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. Neuroreport 1997;8:3439-42. (Pubitemid 27497460)
156. Cui Q, Yip HK, Zhao RC, So KF, Harvey AR. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci 2003;22:49-61. (Pubitemid 36269115)
157. Watanabe M, Tokita Y, Kato M, Fukuda Y. Intravitreal injections of neuro trophic factors and forskolin enhance survival and axonal regenera tion of axotomized beta ganglion cells in cat retina. Neuroscience 2003;116:733-42. (Pubitemid 36160569)
158. MacLaren RE, Buch PK, Smith AJ, Balaggan KS, MacNeil A, Taylor JS, et al. CNTF gene transfer protects ganglion cells in rat retinae undergoing focal injury and branch vessel occlusion. Exp Eye Res 2006;83:1118-27. (Pubitemid 44397032)
159. Kang SS, Keasey MP, Cai J, Hagg T. Loss of neuron-astroglial interaction rapidly induces protective CNTF expression after stroke in mice. J Neurosci 2012;32:9277-87.
160. Wang L, Ma W, Markovich R, Lee WL, Wang PH. Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 1998;139:1354-60. (Pubitemid 28510157)
161. Wang L, Ma W, Markovich R, Chen JW, Wang PH. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 1998;83:516-22. (Pubitemid 28411053)
162. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010;120:254-65.
163. Vivar R, Humeres C, Varela M, Ayala P, Guzman N, Olmedo I, et al. Cardiac fibroblast death by ischemia/reperfusion is partially inhibited by IGF-1 through both PI3K/Akt and MEK-ERK pathways. Exp Mol Pathol 2012;93:1-7.
164. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995;270:13585-8.
165. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits
166. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulinlike growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997;17:1595-606. (Pubitemid 27097389)
167. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-6.
168. Bronson SK, Reiter CE, Gardner TW. An eye on insulin. J Clin Invest 2003;111:1817-9. (Pubitemid 38057725)
169. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004;59:21-6. (Pubitemid 38610223)
170. Lillien L. Changes in retinal cell fate induced by overexpression of EGF receptor. Nature 1995;377:158-62.
171. Wan J, Ramachandran R, Goldman D. HB-EGF is necessary and sufficient for Muller glia dedifferentiation and retina regeneration. Dev Cell 2012;22:334-47.
172. Czekaj M, Haas J, Gebhardt M, Muller-Reichert T, Humphries P, Farrar J, et al. In vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes. PLoS One 2012;7:e41798.
173. Ueki Y, Karl MO, Sudar S, Pollak J, Taylor RJ, Loeffler K, et al. P53 is required for the developmental restriction in Muller glial proliferation in mouse retina. Glia 2012;60:1579-89.
174. Munemasa Y, Chang CS, Kwong JM, Kyung H, Kitaoka Y, Caprioli J, et al. The neuronal EGF-related gene Nell2 interacts with Macf1 and supports survival of retinal ganglion cells after optic nerve injury. PLoS One 2012;7:e34810.
175. D'Onofrio PM, Thayapararajah M, Lysko MD, Magharious M, Spratt SK, Lee G, et al. Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A. J Neurotrauma 2011;28:1863-79.
176. Borlongan CV, Hess DC. New hope for stroke patients: mobilization of endogenous stem cells. CMAJ 2006;174:954-5.
177. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003;111:1843-51. (Pubitemid 38057729)
178. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature 2005;438:954-9. (Pubitemid 43093961)
179. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 2000;97:10242-7.
180. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999;19:5731-40. (Pubitemid 29327910)
181. Lapish CC, Belardetti F, Ashby DM, Ahn S, Butts KA, So K, et al. A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer. Int J Neuropsychopharmacol 2011:1-15.
182. Tengel T, Alcocer MJ, Schleucher J, Larsson G. Complete assignment and secondary structure of the Brazil nut allergen Ber e 1. J Biomol NMR 2005;32:336. (Pubitemid 41511517)
183. Wang D, Guo M, Liang Z, Fan J, Zhu Z, Zang J, et al. Crystal structure of human vacuolar protein sorting protein 29 reveals a phosphodiesterase/nuclease- like fold and two protein-protein inter action sites. J Biol Chem 2005;280:22962-7. (Pubitemid 40853205)
184. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem 1992;59:358-63.
185. Neal MJ, Cunningham JR, Hutson PH, Hogg J. Effects of ischaemia on neurotransmitter release from the isolated retina. J Neurochem 1994;62:1025-33. (Pubitemid 24064514)
186. Brandstatter JH, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci 1994;6:1100-12. (Pubitemid 24218385)
187. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-76.
188. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci 1995;18:57-8.
189. Ullian EM, Barkis WB, Chen S, Diamond JS, Barres BA. Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol Cell Neurosci 2004;26:544-57. (Pubitemid 38969951)
190. Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis 2011;2:e240.
191. Husain S, Abdul Y, Potter DE. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des 2012 Jun. 28. [Epub ahead of print]
192. Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985;65:101-48. (Pubitemid 15165386)
193. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium 1998;23:173-80. (Pubitemid 28188002)
194. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999;79:1431-568. (Pubitemid 29473320)
195. Garcia ML, Usachev YM, Thayer SA, Strehler EE, Windebank AJ. Plasma membrane calcium ATPase plays a role in reducing Ca (2+) - mediated cytotoxicity in PC12 cells. J Neurosci Res 2001;64:661-9. (Pubitemid 32520689)
196. Limbrick DD Jr, Pal S, DeLorenzo RJ. Hippocampal neurons exhibit both persistent Ca2+ influx and impairment of Ca2+ sequestration/extrusion mechanisms following excitotoxic glutamate exposure. Brain Res 2001;894:56-67. (Pubitemid 32197598)
197. Rintoul GL, Raymond LA, Baimbridge KG. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells. Cell Calcium 2001;29:277-87. (Pubitemid 32266394)
198. Wang C, Nguyen HN, Maguire JL, Perry DC. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J Cereb Blood Flow Metab 2002;22:206-14. (Pubitemid 34135651)
199. Brandt SK, Weatherly ME, Ware L, Linn DM, Linn CL. Calcium preconditioning triggers neuroprotection in retinal ganglion cells. Neuro science 2011;172:387-97.
200. Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006;12:628-35.
201. Webster KA, Discher DJ, Bishopric NH. Cardioprotection in an in vitro model of hypoxic preconditioning. J Mol Cell Cardiol 1995;27:453-8.
202. Youssef FF, Addae JI, Stone TW. NMDA-induced preconditioning attenuates synaptic plasticity in the rat hippocampus. Brain Res 2006;1073-1074:183-9.
203. Wehrwein E, Thompson SA, Coulibaly SF, Linn DM, Linn CL. Acetylcholine protection of adult pig retinal ganglion cells from glutamateinduced excitotoxicity. Invest Ophthalmol Vis Sci 2004;45:1531-43. (Pubitemid 38859335)
204. Thompson SA, Smith O, Linn DM, Linn CL. Acetylcholine neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through alpha4 nAChRs. Exp Eye Res 2006;83:1135-45. (Pubitemid 44404133)
205. Asomugha CO, Linn DM, Linn CL. ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs. J Neurochem 2010;112:214-26.
206. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6. (Pubitemid 10070336)
207. Franco R, Bortner CD, Cidlowski JA. Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis. J Membr Biol 2006;209:43-58. (Pubitemid 43725455)
208. Bortner CD, Cidlowski JA. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 2007;462:176-88. (Pubitemid 46863418)
209. Bortner CD, Hughes FM Jr, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997;272:32436-42. (Pubitemid 28011927)
210. Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 1997;272:30567-76. (Pubitemid 27512272)
211. Koeberle PD, Schlichter LC. Targeting K (V) channels rescues retinal ganglion cells in vivo directly and by reducing inflammation. Channels (Austin) 2010;4:337-46.
212. Koeberle PD, Wang Y, Schlichter LC. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 2010;17:134-44.
213. Yuan H, Wang WP, Feng N, Wang L, Wang XL. Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. Eur J Pharmacol 2011;657:76-83.
214. Shen QJ, Zhao YM, Cao DX, Wang XL. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons. J Neurosci Res 2009;87:3153-60.
215. Zaks-Makhina E, Kim Y, Aizenman E, Levitan ES. Novel neuro protective K+ channel inhibitor identified by high-throughput screening in yeast. Mol Pharmacol 2004;65:214-9. (Pubitemid 38113902)
216. Cotella D, Hernandez-Enriquez B, Wu X, Li R, Pan Z, Leveille J, et al. Toxic role of K+ channel oxidation in mammalian brain. J Neurosci 2012;32:4133-44.
217. Dallas ML, Boyle JP, Milligan CJ, Sayer R, Kerrigan TL, McKinstry C, et al. Carbon monoxide protects against oxidant-induced apoptosis via inhibi tion of Kv2.1. FASEB J 2011;25:1519-30.